The United Kingdom government has detailed what it hopes to get out of its Brexit trade deal talks with the European Union. UK officials are seeking multiple provisions intended to facilitate trade in medicinal products, for example by proposing for each side to recognize good manufacturing practice (GMP) certificates issued by the other.
Unlike the European Commission, which provided scant details of its thinking about medicines and medical devices in its negotiating guidelines, the UK government detailed multiple specific objectives related to the industry in a document outlining its approach to the talks. The UK government wants an annex on medicinal products designed to facilitate cross-border trade and “support high levels of patient safety.”
Specific goals include the aforementioned mutual recognition of GMP certificates. The UK also wants to agree to mutual recognition of batch testing certificates, citing the Comprehensive Economic and Trade Agreement between the EU and Canada as a suitable framework for that part of the deal.
Other parts of the document also look to existing relationships between the EU and other countries for inspiration. If the EU agrees, the reuse of elements of existing agreements could cut the time it takes to strike a deal, thereby helping the UK to hit the tight deadline for completing negotiations…